wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38654762-0EBBF758-F13B-49A5-B0AE-967411ACC14B
Q38654762-0EBBF758-F13B-49A5-B0AE-967411ACC14B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38654762-0EBBF758-F13B-49A5-B0AE-967411ACC14B
SGLT2 inhibitors and risk of cancer in type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials.
P2860
Q38654762-0EBBF758-F13B-49A5-B0AE-967411ACC14B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38654762-0EBBF758-F13B-49A5-B0AE-967411ACC14B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e3b2385e4023fb8516575dcf1eff48be443d0f97
P2860
Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone.